Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New FSH receptor agonists disclosed by Merck KGaA for female infertility

July 26, 2013

Presentation of the data from clinical trials of dulaglutide

July 26, 2013

New biomaterial coatings to improve bone-bioimplant interface stability

July 24, 2013

Ligand signs license agreement with Azure Biotech for lasofoxifene

July 24, 2013

Daiichi Sankyo and Ube Industries synthesize new CETP inhibitors

July 24, 2013

Novel agents for metabolic diseases disclosed by Cadila Healthcare

July 24, 2013

New ACC-beta inhibitors synthesized by Boehringer Ingelheim

July 23, 2013

Reviva Pharmaceuticals describes monoamine transporter inhibitors

July 22, 2013

GSK-2330672 demonstrates significant effects on bile acid excretion and synthesis in phase I trial

July 22, 2013

Pfizer reports novel GHR antagonist antibodies

July 19, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...